Pono Capital Four, Inc. PONOU
Set alert
At close · Oct 28
After hours · Oct 28, 4:00 PM ET
- YTD
- +2.21%
- 1 year
- +2.21%
- Open
- 10.36
- Prev close
- 10.18
- Mkt cap
- 124.25M
- Vol
- 154
- Avg vol
- 6
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 10.18
- High
- 10.18
- Forward P/E
- 0.00
- Beta
- 0.00
- Short ratio
- 0.10
- Inst. own
- 6.48%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 10.53
- 200-d avg
- 10.24
- 1y target
- 0.00
News
2 months ago globenewswire.com
Blackstar Orbital Technologies, an innovative developer of advanced reusable spacecraft announces the signing of a definitive agreement to go public via a business combination with Pono Capital Four, a Nasdaq listed company.
George Town, Grand Cayman, Cayman Islands, Aug. 06, 2026 (GLOBE NEWSWIRE) -- Pono Capital Four, Inc. (NASDAQ: PONO, PONOU and PONOR), a special purpose acquisition company (“Pono”), has announced the…
6 months ago globenewswire.com
Pono Capital Four, Inc. Announces the Separate Trading of its Class A Ordinary Shares and Share Rights Commencing May 5, 2026
George Town, Grand Cayman, Cayman Islands, May 01, 2026 (GLOBE NEWSWIRE) -- Pono Capital Four, Inc. (Nasdaq: PONO) (the “Company”) today announced that, commencing May 5, 2026, holders of the units…
7 months ago accessnewswire.com
D. Boral Capital Acted as Sole Bookrunner to Pono Capital Four, Inc. (Nasdaq: PONOU) in Connection with its $120,000,000 Initial Public Offering
NEW YORK, NY / ACCESS Newswire / March 17, 2026 / On March 16, 2026, Pono Capital Four, Inc. (Nasdaq:PONOU) (or the "Company") announced the closing of its Initial Public Offering of 12,000,000 units…
-
4 years ago benzinga.com
Pono Capital Corp Combination Partner Benuvia Receives Approval From DEA To Manufacture Psychedelic Active Pharmaceutical Ingredients including Psilocybin, MDMA And DMT
With this approval, Benuvia has begun focusing on four primary psychedelic ingredients: Psilocybin, N,N-Dimethyl-5-Methoxy-Tryptamine (5-MeO DMT), Dimethyltryptamine (DMT), and…
-
4 years ago benzinga.com
Benuvia To Go Public Via SPAC Deal With Pono Capital, Deal Valued At $440M
Benuvia, a leading drug developer focused on pharmaceutical cannabinoids has entered into a definitive business combination agreement with Pono Capital Corp (NASDAQ:PONO) The transaction implies a…